SOURCE: S3 Investment Company, Inc.

January 23, 2007 09:00 ET

S3 Investment Company CEO Completes China Trip With Visits to Prospective Redwood Capital Clients and Preparation for New SINO UJE Product Line

TEMECULA, CA -- (MARKET WIRE) -- January 23, 2007 -- S3 Investment Company, Inc. (PINKSHEETS: SEIH), a holding company with two subsidiaries doing business in the China market, today announced that CEO Jim Bickel has returned from a trip to China. During his trip, Mr. Bickel met with several new prospective clients for S3 subsidiary Redwood Capital and was briefed on subsidiary SINO UJE's preparations for the launch of the Abaxis product line in China.

Redwood Capital, which assists private Chinese companies in accessing U.S. capital markets through a reverse merger process, has identified and is in final negotiations to sign several new client companies. These prospective clients do business in a variety of industries, including agribusiness, construction materials, paper pulp processing and food production. They are located in the Chinese cities of Beijing, Shendong and Dalian.

"Our site visits were extremely fruitful, and each of these companies are strong candidates for introduction to the U.S. public markets," stated Mr. Bickel. "We look forward to pursuing signed contracts with all of them. What makes these prospective Redwood clients unique is that they each have a technological advantage or attractive niche market that they serve, which we expect will increase interest in the U.S. investment community."

While in Beijing, Mr. Bickel met with the staff of the Redwood registered office. Redwood's managing director, Charlie Wu, accompanied Mr. Bickel on the site visits.

In conjunction with his review of prospective Redwood Capital clients, Mr. Bickel met with Chief Capital General Manager Dr. Hu Cheng. Redwood anticipates hiring Chief to work with all future clients it represents and will utilize Chief's expertise in restructuring companies for the reverse merger process and overseeing audits of their financial information in preparation for the mergers.

Mr. Bickel also traveled to Shanghai, to the direct offices of SINO UJE. SINO UJE is currently preparing for the launch of the product line of new supplier Abaxis, Inc., a publicly traded company that develops, manufactures and markets portable blood analysis systems for use in patient-care setting to provide clinicians with rapid blood constituent measurements. Once SFDA approval is achieved in China, SINO UJE expects to have in place a comprehensive sales and marketing effort on behalf of the Abaxis products.

"The Abaxis product line has the potential to be the single biggest revenue producer in the SINO UJE distribution network, so preparation to roll-out its blood analysis systems is critical, even before SFDA approval is achieved. Managing director Li Jun and his staff are dedicating significant time to the Abaxis product launch, even as they continue to expand distribution of the existing SINO UJE product catalogue," added Mr. Bickel.

To sign up to receive information by email directly from S3 Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit

About S3 Investment Company

S3 Investment Company, Inc. ( is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (, which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (, a non-stocking distributor of medical and industrial high-tech products to markets throughout China. SINO UJE has been granted exclusive distribution rights in China to medical and industrial products manufactured by leading companies in Europe, North America and Japan. These products are marketed to end-users, including major Chinese hospitals and private companies in a variety of fields, as well as original equipment manufacturers (OEMs), such as Phillips, Siemens and GE, that package the products with their technologies.

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    (951) 587-8072
    Email Contact